as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹548.45
Change
-2.8 (-0.51%)
Open
₹552.0
Prev. Close
₹551.25
Day High
₹552.0
Day Low
₹542.1
Volume Analysis
Traded
23,523
Delivered
11,358
Delivery %
48.28%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (27.0%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (3)
- •Strong 3-year EPS growth (16.5%)
- •Strong 3-year revenue growth (16.7%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹562.84 | ₹557.42 | ₹552.94 | ₹547.52 | ₹543.04 | ₹537.62 | ₹533.14 |
| Fibonacci | ₹557.42 | ₹553.64 | ₹551.3 | ₹547.52 | ₹543.74 | ₹541.4 | ₹537.62 |
| Camarilla | ₹551.17 | ₹550.27 | ₹549.36 | ₹547.52 | ₹547.54 | ₹546.64 | ₹545.73 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-25.93%
1 Week
-1.12%
1 Month
-2.77%
3 Months
+0.86%
6 Months
-2.26%
1 Year
-30.87%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹460.96
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.3%
Net margin 11.9% × asset turnover 0.42x × equity multiplier 1.86x
Company Overview
Sector
Healthcare
Market Cap
₹1,785 Cr
P/E (TTM)
18.3
ROE
10.9%
Book Value
₹302.0
Face Value
₹5.0
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Krsnaa Diagnostics Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 59/100. The strongest factor is Growth (88/100), while Momentum (13/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (27.0%); promoter holding is falling. Strong 3-year EPS growth (16.5%).
TopFund Score — Fundamentals Quality
59/100 — AverageData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Promoter holding is low: 27.1%
- −Company has a low return on equity of 9.02% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Krsnaa executes 15-year PPP concession for PET-CT facilities at 4 Punjab hospitals.
Krsnaa Diagnostics dispatched FY2025-26 annual report; 16th AGM scheduled for September 28, 2026.
CIT(A), Pune passed seven income-tax orders for AY2017-18 to AY2023-24; disputed demand totals ₹62.69 crore.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 140 | 155 | 158 | 166 | 170 | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 |
| Expenses + | 108 | 124 | 121 | 123 | 128 | 137 | 129 | 133 | 142 | 147 | 135 | 138 | 178 |
| Operating Profit | 31 | 32 | 37 | 44 | 43 | 49 | 45 | 53 | 51 | 59 | 46 | 55 | 58 |
| OPM % | 22.0% | 20.0% | 24.0% | 26.0% | 25.0% | 27.0% | 26.0% | 28.0% | 27.0% | 29.0% | 26.0% | 28.0% | 25.0% |
| Other Income + | 4 | 4 | 4 | 4 | 7 | 5 | 9 | 4 | 4 | 4 | 4 | 32 | 7 |
| Interest | 2 | 3 | 4 | 7 | 5 | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 |
| Depreciation | 16 | 19 | 21 | 18 | 21 | 22 | 23 | 22 | 22 | 24 | 23 | 23 | 28 |
| Profit before tax | 18 | 13 | 16 | 23 | 23 | 25 | 25 | 29 | 27 | 32 | 20 | 52 | 22 |
| Tax % | 18.0% | 22.0% | 19.0% | 17.0% | 23.0% | 23.0% | 24.0% | 28.0% | 25.0% | 24.0% | 23.0% | 19.0% | 26.0% |
| Net Profit + | 15 | 10 | 13 | 19 | 18 | 20 | 19 | 21 | 21 | 24 | 15 | 42 | 17 |
| EPS in Rs | 5 | 3 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 5 | 13 | 5 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 39 | 61 | 455 | 487 | 620 | 717 | 773 | 815 |
| Expenses + | 30 | 42 | 324 | 365 | 475 | 527 | 561 | 597 |
| Operating Profit | 9 | 19 | 132 | 122 | 144 | 190 | 212 | 218 |
| OPM % | 23.0% | 31.0% | 29.0% | 25.0% | 23.0% | 27.0% | 27.0% | 27.0% |
| Other Income + | 3 | 2 | 15 | 19 | 17 | 26 | 43 | 47 |
| Interest | 9 | 9 | 18 | 8 | 16 | 25 | 34 | 43 |
| Depreciation | 6 | 12 | 41 | 54 | 75 | 88 | 90 | 97 |
| Profit before tax | -3 | 0 | 87 | 80 | 70 | 103 | 130 | 125 |
| Tax % | 49.0% | 180.0% | 21.0% | 23.0% | 19.0% | 24.0% | 22.0% | — |
| Net Profit + | -5 | 0 | 68 | 62 | 57 | 78 | 101 | 97 |
| EPS in Rs | -10 | 0 | 22 | 20 | 18 | 24 | 31 | 30 |
| Dividend Payout % | 0.0% | 0.0% | 11.0% | 14.0% | 14.0% | 11.0% | 6.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 6 | 6 | 669 | 723 | 794 | 867 | 964 |
| Borrowings + | 131 | 102 | 41 | 32 | 160 | 204 | 534 |
| Other Liabilities + | 44 | 80 | 150 | 137 | 201 | 192 | 304 |
| Total Liabilities | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,819 |
| Fixed Assets + | 74 | 131 | 386 | 471 | 647 | 670 | 656 |
| CWIP | 20 | 6 | 28 | 25 | 10 | 3 | 208 |
| Investments | 1 | 1 | 0 | 0 | 0 | 32 | 57 |
| Other Assets + | 91 | 55 | 461 | 412 | 513 | 573 | 897 |
| Total Assets | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,819 |
| Equity Capital | 5 | 5 | 16 | 16 | 16 | 16 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -23 | 64 | 128 | 76 | 24 | 87 | 143 |
| Cash from Investing Activity + | -47 | -54 | -241 | -109 | -129 | -100 | -396 |
| Cash from Financing Activity + | 105 | -41 | 176 | -33 | 84 | 14 | 279 |
| Net Cash Flow | 36 | -31 | 64 | -66 | -20 | 1 | 26 |
| CFO/OP | -254 | 344 | 103 | 73 | 30 | 56 | 81 |
| Free Cash Flow | -69 | 10 | -3 | -58 | -169 | -24 | -72 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 49.79% | 52.94% | 54.27% | 54.23% | 53.34% | 54.27% | 54.94% | 55.25% | 54.27% | 54.86% | 55.09% | 54.08% |
| Promoters | 27.79% | 27.03% | 27.03% | 27.17% | 27.17% | 27.24% | 27.24% | 27.11% | 27.11% | 27.11% | 27.11% | 27.11% |
| FII | 3.68% | 3.44% | 3.34% | 3.33% | 3.63% | 4.04% | 3.55% | 3.4% | 3.66% | 4.17% | 3.91% | 4.28% |
| DII | 18.73% | 16.59% | 15.37% | 15.26% | 15.86% | 14.46% | 14.26% | 14.24% | 14.96% | 13.85% | 13.89% | 14.51% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Krsnaa Diagnostics Ltd (this stock) | 1,785 | 18.3 | 1.81 | 10.9% |
| Suraksha Diagnostic Ltd | 1,788 | 49.9 | 7.3 | 14.2% |
| Ngl Fine Chem Limited | 1,796 | 31.4 | 5.45 | 17.4% |
| Tarsons Products Limited | 1,770 | 150.0 | 2.8 | 2.44% |
| Hester Biosciences Ltd | 1,884 | 35.5 | 5.24 | 15.9% |
| Syncom Formu (i) Ltd | 1,885 | 22.0 | 4.54 | 17.6% |
| Anlon Healthcare Limited | 1,655 | 52.3 | 7.18 | 18.4% |
Which Mutual Funds Hold Krsnaa Diagnostics Ltd?
Frequently Asked Questions about Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd (KRSNAA) closed at ₹548.45 on NSE on 25 September 2026, down 2.8 (0.51%) from the previous close.
Krsnaa Diagnostics Ltd trades on the NSE (National Stock Exchange of India) under the symbol KRSNAA.
Krsnaa Diagnostics Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 18.3.
Krsnaa Diagnostics Ltd has a dividend yield of 0.36%.
Krsnaa Diagnostics Ltd's 52-week high is ₹849.0 and its 52-week low is ₹502.0.
Krsnaa Diagnostics Ltd has a market capitalisation of ₹1,785 crore.
Krsnaa Diagnostics Ltd has a TopFund Quality Score of 59/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Krsnaa Diagnostics Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.